1064-nm Q-switched fractional Nd:YAG laser is safe and effective for the treatment of post-surgical facial scars.


Journal

Lasers in medical science
ISSN: 1435-604X
Titre abrégé: Lasers Med Sci
Pays: England
ID NLM: 8611515

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 13 03 2020
accepted: 20 08 2020
pubmed: 28 8 2020
medline: 28 5 2021
entrez: 27 8 2020
Statut: ppublish

Résumé

Post-surgical facial scars are often associated with unaesthetic outcome. Treatment of these scars using various lasers could be beneficial; however, the use of the Q-switched fractional (QSF) 1064-nm neodymium-doped yttrium aluminum garnet (Nd:YAG) laser has yet to be evaluated for this indication. Our objective was to determine the safety and efficacy of a QSF-Nd:YAG laser for the treatment of post-surgical facial scars. Eleven (5 male, 6 female) patients who underwent facial surgery with significant scarring were treated using the QSF-Nd:YAG laser. Scars were exposed to 600-1200 mJ/stacked pulses (12-24 mJ per pixel), emitted at a rate of 10 Hz for up to 2 passes per treatment session, receiving overall 3-6 treatments. Patient follow-up was 3 months. Scars' photographs were blindly assessed by two dermatologists, who graded them on a scale of scar severity from 1 to 5 (1 = least severe, 5 = most severe) before and after treatment. A blinded before/after recognition of these photographs was also performed. Patient satisfaction was assessed 3 months post-treatment and graded on a scale of 1-5 (1 = not satisfied, 5 = very satisfied). Pain perception and adverse effects were also evaluated. Patients demonstrated a decrease in scar severity score by a mean of 1.57 points (p = 0.0005). A blinded before/after recognition was correct in 86.5% of the cases. Pain and adverse effects were mild and transient. Patient satisfaction was high (4.2). QSF-Nd:YAG laser is a safe and effective modality for the treatment of post-surgical facial scars.

Identifiants

pubmed: 32845427
doi: 10.1007/s10103-020-03134-8
pii: 10.1007/s10103-020-03134-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

871-874

Références

Young VL, Hutchison J (2009) Insights into patient and clinician concerns about scar appearance: semiquantitative structured surveys. Plast Reconstr Surg 124(1):256–265
doi: 10.1097/PRS.0b013e3181a80747
Ward RE, Sklar LR, Eisen DB (2019) Surgical and noninvasive modalities for scar revision. Dermatol Clin 37(3):375–386. https://doi.org/10.1016/j.det.2019.03.007
doi: 10.1016/j.det.2019.03.007 pubmed: 31084731
Politi Y, Levi A, Lapidoth M (2016) Integrated cooling-vacuum- assisted non-fractional 1540 nm erbium:glass laser is effective in treating acne scars. J Drugs Dermatol 15(11):1359–1363
pubmed: 28095548
Politi Y, Levi A, Enk CD, Lapidoth M (2015) Integrated cooling-vacuum-assisted 1540-nm erbium:glass laser is effective in treating mild-to-moderate acne vulgaris. Lasers Med Sci 30(9):2389–2393
doi: 10.1007/s10103-015-1816-4
Tidwell WJ, Owen CE, Kulp-Shorten C, Maity A, McCall M, Brown TS (2016) Fractionated Er:YAG laser versus fully ablative Er:YAG laser for scar revision: results of a split scar, double blinded, prospective trial. Lasers Surg Med 48(9):837–843
doi: 10.1002/lsm.22562
Vas K, Gaál M, Varga E et al (2014) Effects of the combined PDL/Nd:YAG laser on surgical scars: vascularity and collagen changes evaluated by in vivo confocal microscopy. Biomed Res Int 2014:1–8
doi: 10.1155/2014/204532
Ezra N, Dodgen T, Arshanapalli A, Somani A-K (2014) Successful use of the microsecond 1,064-nm Nd. Dermatologic Surg 40(12):1420–1422
doi: 10.1097/01.DSS.0000452653.52507.d4
Cho SB, Lee JH, Lee SH, Lee SJ, Bang D, Oh SH (2010) Efficacy and safety of 1064-nm Q-switched Nd:YAG laser with low fluence for keloids and hypertrophic scars. J Eur Acad Dermatol Venereol 24(9):1070–1074
pubmed: 20158584
Badawi A, Tome MA, Atteya A, Sami N, Morsy IAL (2011) Retrospective analysis of non-ablative scar treatment in dark skin types using the sub-millisecond Nd:YAG 1,064 nm laser. Lasers Surg Med 43(2):130–136
doi: 10.1002/lsm.21031
Sherman R, Rosenfeld H (1988) Experience with the Nd:YAG laser in the treatment of keloid scars. Ann Plast Surg 21(3):231–235
doi: 10.1097/00000637-198809000-00007
Akaishi S, Koike S, Dohi T, Kobe K, Hyakusoku H, Ogawa R (2012) Nd:YAG laser treatment of keloids and hypertrophic scars. Eplasty. 12:e1
pubmed: 22259645 pmcid: 3258100
Maluki AH, Mohammad FH (2012) Treatment of atrophic facial scars of acne vulgaris by Q-switched Nd:YAG (neodymium: yttrium-aluminum-garnet) laser 1064 nm wavelength. J Cosmet Laser Ther 14(5):224–233
doi: 10.3109/14764172.2012.723807
Al-Dhalimi M, Jaber A (2015) Treatment of atrophic facial acne scars with fractional Er:Yag laser. J Cosmet Laser Ther 17(4):184–188
doi: 10.3109/14764172.2015.1007067
Sadick NS, Cardona A (2018) Laser treatment for facial acne scars: a review. J Cosmet Laser Ther 20(7–8):424–435
doi: 10.1080/14764172.2018.1461230

Auteurs

Lehavit Akerman (L)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Efrat Solomon-Cohen (E)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. efratsolomon@gmail.com.
Laser Unit, Division of Dermatology, Rabin Medical Center, Petah-Tikva, Israel. efratsolomon@gmail.com.

Mati Rozenblat (M)

Department of Dermatology, Emek Medical Center, Afula, Israel.

Emmilia Hodak (E)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Laser Unit, Division of Dermatology, Rabin Medical Center, Petah-Tikva, Israel.

Moshe Lapidoth (M)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Laser Unit, Division of Dermatology, Rabin Medical Center, Petah-Tikva, Israel.

Assi Levi (A)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Laser Unit, Division of Dermatology, Rabin Medical Center, Petah-Tikva, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH